severity of pain. -
Conditions
Interventions
Intervention 1: Intervention1: The researcher extracted 5 cc of this medicine by syringe needle as code No.21, and after forcing out air through syringe needle, he changed the needle, and put the lab
Treatment - Other
Intervention1: The researcher extracted 5 cc of this medicine by syringe needle as code No.21, and after forcing out air through syringe needle, he changed the needle, and put the labeled code "1"(in
Intervention1: The researcher extracted 5 cc of this medicine by syringe needle as code No.21, and after forcing out air through syringe needle, but not changed the needle, and put the labeled code "
Sponsors
Medical Science Vice chancellor for research Arvand International University
Medical Science Vice chancellor for research Ahvaz Jundishapur University of Medical Science
Eligibility
Sex/Gender
Female
Age
18 Years to 58 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: The age should be over 18 and under 58 years; Holding the permission of intramuscular injection of Metocarbamul medicine; Not committing intramuscular injection within the last week; Having body mass of 19-25; Being conscious of the ill person; Non using any pain killer medicine prior to injection Exclusion critwria: study existence of blue-dark, reddish marks and inflammation and wound in the place of injection; Having record of diabetic.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of pain. Timepoint: After finishing injection,measuring patent pain. Method of measurement: Visual Analogue Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBahram Abdali
Arvad International University
Outcome results
None listed